Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$335.16
At close: Aug 19 EDT
$334.67
-0.49-0.15%
Pre-Market: 4:04 AM EDT
Comments
Loading...
Tesla Analyst Ratings and Price Targets | NASDAQ:TSLA | Benzinga
Tesla Inc has a consensus price target of $311.81 based on the ratings of 29 analysts. The high is $500 issued by Wedbush on August 4, 2025. The low is $19.05 issued by GLJ Research on July 24, 2025. The 3 most-recent analyst ratings were released by Wedbush, RBC Capital, and China Renaissance on August 4, 2025, July 29, 2025, and July 25, 2025, respectively. With an average price target of $391.33 between Wedbush, RBC Capital, and China Renaissance, there's an implied 16.93% upside for Tesla Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wedbush
RBC Capital
China Renaissance
GLJ Research
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Tesla
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
08/04/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/29/2025 | -2.89% | RBC Capital | $319 → $325 | Maintains | Outperform | |||
07/25/2025 | 4.28% | China Renaissance | — | → $349 | Downgrade | Buy → Hold | ||
07/24/2025 | -94.31% | GLJ Research | $19.05 → $19.05 | Reiterates | Sell → Sell | |||
07/24/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/24/2025 | 6.07% | Cantor Fitzgerald | $355 → $355 | Reiterates | Overweight → Overweight | |||
07/24/2025 | — | Needham | — | Maintains | Hold | |||
07/23/2025 | -47.71% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/22/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/21/2025 | 1.89% | B of A Securities | $305 → $341 | Maintains | Neutral | |||
07/11/2025 | -14.84% | Goldman Sachs | $315 → $285 | Maintains | Neutral | |||
07/08/2025 | 12.05% | Mizuho | $390 → $375 | Maintains | Outperform | |||
07/08/2025 | -47.71% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
07/08/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
07/07/2025 | — | William Blair | — | Downgrade | Outperform → Market Perform | |||
07/03/2025 | -5.88% | Goldman Sachs | $285 → $315 | Maintains | Neutral | |||
07/03/2025 | -64.14% | HSBC | $120 → $120 | Reiterates | Reduce → Reduce | |||
07/01/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/30/2025 | -9.46% | Canaccord Genuity | $303 → $303 | Maintains | Buy | |||
06/26/2025 | 41.93% | Benchmark | $350 → $475 | Maintains | Buy | |||
06/23/2025 | -47.71% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
06/23/2025 | -35.76% | UBS | $190 → $215 | Maintains | Sell | |||
06/23/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/20/2025 | 49.4% | Wedbush | $500 → $500 | Reiterates | Outperform → Outperform | |||
06/11/2025 | 19.52% | Piper Sandler | $400 → $400 | Reiterates | Overweight → Overweight | |||
06/09/2025 | 22.51% | Morgan Stanley | $410 → $410 | Reiterates | Overweight → Overweight | |||
06/09/2025 | — | Argus Research | — | Downgrade | Buy → Hold | |||
06/09/2025 | -4.38% | Baird | $320 → $320 | Downgrade | Outperform → Neutral | |||
06/06/2025 | -14.84% | Goldman Sachs | $295 → $285 | Maintains | Neutral | |||
05/23/2025 | 49.4% | Wedbush | $350 → $500 | Maintains | Outperform | |||
05/16/2025 | 16.53% | Mizuho | $325 → $390 | Maintains | Outperform | |||
05/06/2025 | -29.78% | Goldman Sachs | $275 → $235 | Reiterates | Neutral → Neutral | |||
05/01/2025 | 4.58% | Wedbush | $350 → $350 | Reiterates | Outperform → Outperform | |||
04/24/2025 | -49.2% | Guggenheim | $170 → $170 | Reiterates | Sell → Sell | |||
04/24/2025 | 34.46% | Stifel | $455 → $450 | Maintains | Buy | |||
04/23/2025 | 4.58% | Benchmark | $350 → $350 | Reiterates | Buy → Buy | |||
04/23/2025 | -2.89% | Mizuho | $375 → $325 | Maintains | Outperform | |||
04/23/2025 | 18.03% | Roth MKM | $450 → $395 | Maintains | Buy | |||
04/23/2025 | -8.27% | RBC Capital | $314 → $307 | Maintains | Outperform | |||
04/23/2025 | -65.64% | JP Morgan | $120 → $115 | Maintains | Underweight | |||
04/23/2025 | 6.07% | Cantor Fitzgerald | $425 → $355 | Maintains | Overweight | |||
04/23/2025 | -9.46% | Canaccord Genuity | $404 → $303 | Maintains | Buy | |||
04/23/2025 | 4.58% | Wedbush | $315 → $350 | Maintains | Outperform | |||
04/23/2025 | -4.38% | Baird | $370 → $320 | Maintains | Outperform | |||
04/23/2025 | -94.31% | GLJ Research | $24.86 → $19.05 | Maintains | Sell | |||
04/23/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
04/22/2025 | -8.87% | B of A Securities | $380 → $305 | Maintains | Neutral | |||
04/17/2025 | -17.83% | Barclays | $325 → $275 | Maintains | Equal-Weight | |||
04/16/2025 | 19.52% | Piper Sandler | $450 → $400 | Maintains | Overweight | |||
04/10/2025 | -43.23% | UBS | $225 → $190 | Maintains | Sell | |||
04/10/2025 | 12.05% | Mizuho | $430 → $375 | Maintains | Outperform | |||
04/09/2025 | 4.58% | Benchmark | $475 → $350 | Maintains | Buy | |||
04/07/2025 | -5.88% | Wedbush | $550 → $315 | Maintains | Outperform | |||
04/03/2025 | -17.83% | Goldman Sachs | $320 → $275 | Maintains | Neutral | |||
04/03/2025 | -16.34% | Truist Securities | $373 → $280 | Maintains | Hold | |||
04/03/2025 | 26.99% | Cantor Fitzgerald | $425 → $425 | Reiterates | Overweight → Overweight | |||
03/31/2025 | 35.95% | Stifel | $474 → $455 | Maintains | Buy | |||
03/28/2025 | 3.09% | Deutsche Bank | $420 → $345 | Maintains | Buy | |||
03/27/2025 | 64.34% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | 64.34% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/21/2025 | 22.51% | Morgan Stanley | $430 → $410 | Maintains | Overweight | |||
03/20/2025 | 64.34% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/20/2025 | 34.46% | Piper Sandler | $500 → $450 | Maintains | Overweight | |||
03/19/2025 | 26.99% | Cantor Fitzgerald | $425 → $425 | Upgrade | Neutral → Overweight | |||
03/18/2025 | -4.38% | RBC Capital | $440 → $320 | Maintains | Outperform | |||
03/17/2025 | 20.72% | Canaccord Genuity | $404 → $404 | Maintains | Buy | |||
03/17/2025 | 28.48% | Mizuho | $515 → $430 | Maintains | Outperform | |||
03/14/2025 | -61.16% | Wells Fargo | $135 → $130 | Maintains | Underweight | |||
03/12/2025 | -64.14% | JP Morgan | $135 → $120 | Maintains | Underweight | |||
03/12/2025 | -49.2% | Guggenheim | $175 → $170 | Maintains | Sell | |||
03/11/2025 | 64.34% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/11/2025 | 20.72% | Canaccord Genuity | $404 → $404 | Maintains | Buy | |||
03/10/2025 | -32.77% | UBS | $259 → $225 | Maintains | Sell | |||
03/07/2025 | 64.34% | Wedbush | $550 → $550 | Reiterates | Outperform → Outperform | |||
03/06/2025 | 10.56% | Baird | $440 → $370 | Maintains | Outperform | |||
03/04/2025 | 13.54% | B of A Securities | $490 → $380 | Maintains | Neutral | |||
03/03/2025 | 28.48% | Morgan Stanley | $430 → $430 | Reinstates | → Top Pick | |||
02/25/2025 | — | Guggenheim | — | Reiterates | Sell → Sell | |||
02/12/2025 | 41.93% | Benchmark | → $475 | Initiates | → Buy | |||
02/12/2025 | -92.57% | GLJ Research | $24.86 → $24.86 | Reiterates | Sell → Sell | |||
02/10/2025 | 41.63% | Stifel | $492 → $474 | Maintains | Buy | |||
02/10/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/31/2025 | -47.71% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
01/30/2025 | -22.61% | UBS | $226 → $259 | Maintains | Sell | |||
01/30/2025 | 53.88% | Mizuho | $515 → $515 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 31.47% | RBC Capital | $440 → $440 | Reiterates | Outperform → Outperform | |||
01/30/2025 | 31.47% | Baird | $480 → $440 | Maintains | Outperform | |||
01/30/2025 | 11.45% | Truist Securities | $351 → $373 | Maintains | Hold | |||
01/30/2025 | 26.99% | Cantor Fitzgerald | $365 → $425 | Maintains | Neutral | |||
01/30/2025 | -59.66% | Wells Fargo | $125 → $135 | Maintains | Underweight | |||
01/30/2025 | — | Needham | — | Reiterates | Hold → Hold | |||
01/29/2025 | -47.71% | Guggenheim | $175 → $175 | Reiterates | Sell → Sell | |||
01/29/2025 | 9.06% | Cantor Fitzgerald | $365 → $365 | Reiterates | Neutral → Neutral | |||
01/22/2025 | 64.34% | Wedbush | $515 → $550 | Maintains | Outperform | |||
01/21/2025 | 49.4% | Piper Sandler | $315 → $500 | Maintains | Overweight | |||
01/15/2025 | -2.89% | Barclays | $270 → $325 | Maintains | Equal-Weight | |||
01/13/2025 | 28.48% | Morgan Stanley | $400 → $430 | Maintains | Overweight | |||
01/07/2025 | 46.41% | B of A Securities | $400 → $490 | Downgrade | Buy → Neutral | |||
01/06/2025 | 47.01% | Stifel | $411 → $492 | Maintains | Buy | |||
01/03/2025 | -17.83% | Evercore ISI Group | $195 → $275 | Maintains | In-Line |
FAQ
What is the target price for Tesla (TSLA) stock?
The latest price target for Tesla (NASDAQ:TSLA) was reported by Wedbush on August 4, 2025. The analyst firm set a price target for $500.00 expecting TSLA to rise to within 12 months (a possible 49.40% upside). 100 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tesla (TSLA)?
The latest analyst rating for Tesla (NASDAQ:TSLA) was provided by Wedbush, and Tesla reiterated their outperform rating.
When was the last upgrade for Tesla (TSLA)?
The last upgrade for Tesla Inc happened on March 19, 2025 when Cantor Fitzgerald raised their price target to $425. Cantor Fitzgerald previously had a neutral for Tesla Inc.
When was the last downgrade for Tesla (TSLA)?
The last downgrade for Tesla Inc happened on July 25, 2025 when China Renaissance changed their price target from N/A to $349 for Tesla Inc.
When is the next analyst rating going to be posted or updated for Tesla (TSLA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tesla, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tesla was filed on August 4, 2025 so you should expect the next rating to be made available sometime around August 4, 2026.
Is the Analyst Rating Tesla (TSLA) correct?
While ratings are subjective and will change, the latest Tesla (TSLA) rating was a reiterated with a price target of $500.00 to $500.00. The current price Tesla (TSLA) is trading at is $334.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
